'The Impact of Rhinovirus Infections in Paediatric Cardiac Surgery'
RISK
1 other identifier
observational
166
1 country
1
Brief Summary
This is a prospective single- center observational study in the Leiden University Medical Center in approximately 250 children (\<12 years) undergoing elective cardiac surgery, for congenital heart disease. The parents/guardians of the children will be asked to fill out a questionnaire, to asses respiratory symptoms in the last weeks, before the operation of their child. In the operating theatre, a nasopharyngeal swab will collected. Clinical data will be collected daily during paediatric intensive care admission, and date of discharge from paediatric intensive care unit and from hospital are recorded. If children are still intubated at day 4 a second nasopharyngeal swab and residual blood will be collected. The samples will be tested for rhinovirus with a polymerase chain reaction. Main study parameter is the paediatric intensive care unit length of stay in per-operative rhinovirus -positive compared to rhinovirus-negative patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2015
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 30, 2015
CompletedFirst Posted
Study publicly available on registry
May 8, 2015
CompletedStudy Start
First participant enrolled
June 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2018
CompletedSeptember 25, 2020
September 1, 2020
3 years
April 30, 2015
September 24, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
post-operative PICU length of stay
rhinovirus PCR positive compared to rhinovirus negative patients
participants will be followed for the duration of PICU stay, an expected average of 3,8 days
Secondary Outcomes (11)
Duration of ventilatory support
participants will be followed for the duration of PICU stay, an expected average of 3,8 days
mean airway pressure
participants will be followed for the duration of PICU stay, an expected average of 3,8 days
FiO2
participants will be followed for the duration of PICU stay, an expected average of 3,8 days
peak inspiratory pressure (maximum values)
participants will be followed for the duration of PICU stay, an expected average of 3,8 days
positive end expiratory pressure (maximum values)
participants will be followed for the duration of PICU stay, an expected average of 3,8 days
- +6 more secondary outcomes
Study Arms (1)
children undergoing cardiac surgery
paediatric patients with a congenital heart disease undergoing elective cardiac surgery
Interventions
rhinovirus PCR on a nasopharyngeal swab
Eligibility Criteria
Children (\<12 year) with a congenital heart disease undergoing elective cardiac surgery
You may qualify if:
- Children (\<12 year) with a congenital heart disease undergoing elective cardiac surgery
- Written informed consent by parents or guardian
You may not qualify if:
- No informed consent from one of the parents (or the legal representative if applicable)
- Anaesthesiologist or cardiopulmonary surgeon postpones surgery based on routine hospital screening
- Emergency surgery
- Pre-operative admission to the neonatology department
- Children not admitted to the intensive care unit after cardiac surgery
- Children undergoing a second cardiac operation during the same intensive care stay
- Children with duct-dependent physiology who remain prostaglandin-dependent after the heart operation (they will be excluded because they will certainly have a prolonged PICU LOS regardless of a possible rhinovirus infection). For example: hypoplastic left heart syndrome following pulmonary artery banding who will remain on prostaglandins until the next staged operation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Leiden University Medical Center
Leiden, Netherlands
Related Publications (1)
Roeleveld PP, Van Rijn AL, de Wilde RBP, van Zwet EW, Wink J, Rozendaal L, Hogenbirk K, Hazekamp MG, Man WH, Sidorov I, Kraakman MEM, Claas ECJ, de Jonge E, Kroes ACM, de Vries JJC. Rhinovirus Detection in the Nasopharynx of Children Undergoing Cardiac Surgery Is Not Associated With Longer PICU Length of Stay: Results of the Impact of Rhinovirus Infection After Cardiac Surgery in Kids (RISK) Study. Pediatr Crit Care Med. 2021 Jan 1;22(1):e79-e90. doi: 10.1097/PCC.0000000000002522.
PMID: 33027243DERIVED
Biospecimen
nasopharyngeal swabs serum EDTA plasma
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anneloes L Klink, Msc
Leiden University Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D. PhD
Study Record Dates
First Submitted
April 30, 2015
First Posted
May 8, 2015
Study Start
June 1, 2015
Primary Completion
June 1, 2018
Study Completion
June 1, 2018
Last Updated
September 25, 2020
Record last verified: 2020-09